UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D


                    Under the Securities Exchange Act of 1934
                            (Amendment No.  1   )*
                        ---------------------------------
                              Ocean Bio-Chem, Inc.
                        ---------------------------------
                                (Name of Issuer)

                                  Common Stock
                                  ------------
                         (Title of Class of Securities)


                                    674631106
                            -------------------------
                                 (CUSIP Number)

                                 Peter G. Dornau
                              Ocean Bio-Chem, Inc.
                              4041 S.W. 47th Avenue
                            Ft. Lauderdale, FL 33314
                             -----------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                 November 13, 2006
                                  -------------
             (Date of Event which Requires Filing of this Statement)



     If the filing  person has  previously  filed a statement on Schedule 13G to
report the acquisition  which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.

     Note:  Schedules filed in paper formal shall included a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

     The  information  required on the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however,  see
the Notes).




1        NAME OF REPORTING PERSON
         S.S. OR IRS. IDENTIFICATION NO. OF ABOVE PERSON
         Peter G. Dornau     065-32-1067

--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)    [   ]
                                                             (b)    [ X ]
--------------------------------------------------------------------------------
3        SEC USE ONLY

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS

--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
           ITEMS 2(d) OR 2(e)                                       [   ]

--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION
         United States of America

--------------------------------------------------------------------------------
7        NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
           VOTING POWER
         5,538,368 (1)

--------------------------------------------------------------------------------
8        NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
           SHARED VOTING POWER
         0

--------------------------------------------------------------------------------
9        NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
           DISPOSITIVE POWER
          5,538,368 (1)

--------------------------------------------------------------------------------
10       NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
           SHARED DISPOSITIVE POWER
         0
                                       2



11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         5,538,368 (1)

--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES SHARES*

--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
         60.9%

--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON*
         INDIVIDUAL



--------------------------------------------------------------------------------
(1) Includes  4,350,368  shares owned as of the date hereof and 1,188,000 shares
which are issuable to Mr.  Peter G. Dornau upon the  exercise of stock  warrants
and options within 60 days of November 13, 2006.




Item 1.  Security and Issuer
         -------------------
     This statement relates to the common stock of Ocean Bio-Chem,  Inc. ("Ocean
Bio-Chem" or the "Company").  The principal executive offices of Ocean Bio-Chem,
Inc. are located at 4041 S.W. 47th Avenue, Fort Lauderdale, FL 33314.

Item 2.  Identity and Background
         -----------------------
     This  Schedule  is being  filed by Peter G.  Dornau,  the  Chief  Executive
Officer,  President and Director of the Ocean Bio-Chem. The business address for
Mr. Dornau 4041 S.W. 47th Avenue,  Fort  Lauderdale,  Florida 33314.  During the
last five years, Mr. Dornau has not been (i) convicted in a criminal  proceeding
(excluding  traffic  violations  or similar  misdemeanors)  or (ii) a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction,
and as a result of such  proceeding  was or is subject to a judgment,  decree or
final  order  enjoining  future  violations  of,  or  prohibiting  or  mandating
activities  subject  to,  federal  or  state  securities  laws  or  finding  any
violations of any such laws.

Item 3.  Source and Amount of Funds or Other Consideration
         -------------------------------------------------
         Not Applicable.
                                       3



Item 4.  Purpose of Transaction
         ----------------------
     Mr. Dornau does not have any present plans or proposals  which relate to or
would result in: (a) the  acquisition by any person of additional  securities of
Ocean  Bio-Chem or the  disposition  of  securities  of Ocean  Bio-Chem,  (b) an
extraordinary  corporate  transaction,  such  as  a  merger,  reorganization  or
liquidation,  involving  Ocean  Bio-Chem,  (c) a sale or  transfer of a material
amount of assets  of Ocean  Bio-Chem,  (d) any  change in the  present  board of
directors  or  management  of Ocean  Bio-Chem,  including  plans or proposals to
change the number or term of directors or to fill any existing  vacancies on the
board, (e) any material change in the present  capitalization or dividend policy
of Ocean Bio-Chem, (f) any other material change in Ocean Bio-Chem's business or
corporate  structure,  (g) any changes in Ocean Bio-Chem's  charter,  by-laws or
instruments  corresponding  thereto  or  other  actions  which  may  impede  the
acquisition  of  control  of  Ocean  Bio-Chem  by any  person,  (h) a  class  of
securities  of  Ocean  Bio-Chem's  to be  delisted  from a  national  securities
exchange or cease being  authorized  to be quoted in an  inter-dealer  quotation
system of  registered  national  securities  association,  (i) a class of equity
securities of Ocean Bio-Chem  becoming  eligible for termination of registration
pursuant to Section 12(g) (4) of the Securities Exchange Acts of 1934 or (j) any
action similar to any of those  enumerated  above. On April 21, 2005,  Gregor M.
Dornau gave his father, Peter G. Dornau, a proxy to vote his 176,960 shares held
by him.  The  effect of this  transaction  gives  Mr.  Dornau  voting  rights to
approximately 52% of the Company's issued and outstanding common stock.



Item 5.  Interest in Securities of the Issuer
         ------------------------------------

     (a)  Mr. Dornau is deemed to  beneficially  own 5,538,368  shares of the
Ocean  Bio-Chem's  common  stock,  representing  approximately  60.9%  of  Ocean
Bio-Chem's  issued and  outstanding  common  stock  plus  warrants  and  options
exercisable  within 60 days of November 13, 2006. This total includes  4,350,368
shares  held  directly  by Mr.  Dornau and  warrants  and  options  to  purchase
1,188,000 shares of the Ocean Bio-Chem's common stock,  exercisable within sixty
days of November 13, 2006.

     (b)  Concurrent  with the  conversion of his debt to equity in the Company,
Mr. Peter G.Dornau  notified his son,  Gregor M. Dornau that he was  terminating
the Voting Agreement,  dated April 21, 2005 between he and his son whereby Peter
G. Dornau was granted voting rights to his son's shares.

                                       4


     (c) During the past sixty (60) days, Mr. Dornau acquired  1,500,000  shares
of the Common Stock of the Company.  Such shares were authorized for issuance by
the  Company's  Board of  Directors on November  13, 2006 upon  conversion,  and
pursuant to the terms , of a revolving  Credit  Agreement dated December 5, 2005
in the amount of $1,500,000 between Mr. Dornau and the Company.


     (d) Not applicable.

     (e) Not applicable.

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         ---------------------------------------------------------------------
           to Securities of the Issuer
           ---------------------------
     Except  as  described   above,   there  are  no  contracts,   arrangements,
understandings  or  relationships  (legal  or  otherwise)  with  respect  to any
securities of Ocean Bio-Chem to which Mr. Dornau is a party or is subject.

Item 7.  Materials to be filed as Exhibits
         ---------------------------------

     7.1 Amended $1,500,000 Revoloving  Subordinated Line of Credit incorporated
by reference to Form 8-K as of December 6, 2005.

     7.2 Voting  Agreement  dated  April 21,  2005  between  Peter G. Dornau and
Gregor M. Dornau incorporated by reference to Schedule 13D as of April 21, 2005

     7.3 Peter G. Dornau Notice of Conversion


                                   SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.




Date:    November 20, 2006         /s/ Peter G. Dornau
                                   ----------------------------------
                                   Peter G. Dornau


                                        5


                                                                     Exhibit 7.3

                                    ANNEX A
                              NOTICE OF CONVERSION


     The undersigned,  idividually and as officer of affiliated entities, hereby
exercises his right to convert  $1,500,000 of his Revolving Line of Credit Note,
dated December 6, 2005 into 1,500,000 shares of common stock based on the agreed
upon conversion price of $1.00 as contained in the aforementioned Note.

Dated:   November 10, 2006

                                   /s/ Peter G. Dornau
                                   ----------------------------------
                                   Peter G. Dornau